arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Vyome Holdings, Inc

HIND
$2.20 ▲ +0.09 (+4.27%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
13 Visible periods
31 Metrics
Absolute Benchmarks
Price Chart
18
Health
Poor
Bearish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, Vyome Holdings, Inc shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $4.8M
Dividend Yield
Revenue Growth -96.0%
Op. Margin None
ROIC None
FCF / Share $-1.73
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$319.71K
↓ -96.0%
Net Income Profit after all expenses
$-10.26M
↓ -43.9%
Operating Margin Operating profit as % of sales
-96.5%
↑ +45.5%
FCF / Share Free cash flow per share
$-1.73
↑ +99.2%
Long-Term Debt Long-term obligations
$13.32M
↑ +34.2%

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • FCF / Net IncomeFCF / Net Income of 0.37x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality
18

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 45 quarters